Aircraft Medical acquires anaesthesia monitoring technology from
Morpheus Medical
17 June 2009
Edinburgh-based Aircraft Medical has acquired Morpheus Medical,
developer of patient monitoring products. Barcelona-based Morpheus is a
leading developer of patient monitoring devices for the anaesthesia and
critical care markets.
Morpheus' lead product, the IoC-View, is designed to measure the
level of consciousness during general anaesthesia, helping to avoid the
risk of patients remaining conscious through a procedure or conversely
of receiving too much anaesthetic, impeding a fast recovery.
Morpheus' technology is the first to allow anesthesiologists and
critical care professionals to record levels of brain activity during
surgery with Symbolic Dynamic EEG, via electrodes and wireless
transmission. Research suggests that such monitoring can help reduce the
number of patients who experience consciousness during procedures.
In addition, it suggests that patients whose anaesthesia is guided by
neuromonitoring have significantly better outcomes in terms of quality
of recovery and reduction in post-operative nausea and vomiting.
Morpheus was founded by Erik Webber Jensen, a world renowned
researcher in the area of level of consciousness assessment during
general anaesthesia. Erik has been involved in the development of
several anaesthesia monitors currently on the market. He will stay with
the Company in the new position of Chief Technology Officer of Barcelona
group.
The acquisition of Morpheus is in line with Aircraft's long-term
strategic aim of developing a broader product offering for the
anaesthesia and critical care markets. Morpheus' expertise in the area
of depth of anaesthesia monitoring devices complements Aircraft's
leadership in laryngoscopy, with the McGrath Series 5, a fully portable
video laryngoscope.
Matt McGrath, CEO of Aircraft, said: "The acquisition of Morpheus
provides us with an excellent platform to expand our product offering in
the anaesthesia and critical care markets and is an important step
towards achieving our strategic goal of becoming a global technology
leader in these markets. We will continue to review appropriate license
and acquisition opportunities to achieve this goal, as well as growing
our business organically."
Erik Webber Jensen, founder of Morpheus, said: "The combination of
Aircraft and Morpheus represents a strong strategic fit for both groups.
Aircraft's competencies in leading edge design and engineering
complement Morpheus' portfolio and technology. Bringing these companies
together greatly strengthens the range of products we can offer to
anesthesiologists and critical care specialists."
Bookmark this page